Voyageur Pharmaceuticals (CVE:VM) Trading Up 18.2% – Should You Buy?

Voyageur Pharmaceuticals Ltd. (CVE:VMGet Free Report) shot up 18.2% during mid-day trading on Thursday . The company traded as high as C$0.20 and last traded at C$0.20. 134,894 shares traded hands during mid-day trading, a decline of 75% from the average session volume of 530,731 shares. The stock had previously closed at C$0.17.

Voyageur Pharmaceuticals Stock Performance

The company has a market capitalization of C$27.89 million, a price-to-earnings ratio of -20.00 and a beta of 0.32. The stock has a 50 day simple moving average of C$0.10 and a 200 day simple moving average of C$0.07. The company has a quick ratio of 0.84, a current ratio of 0.17 and a debt-to-equity ratio of 3.21.

Voyageur Pharmaceuticals Company Profile

(Get Free Report)

Voyageur Pharmaceuticals Ltd., together with its subsidiaries, engages in the acquiring, exploring, and developing raw materials for pharmaceutical products, primarily in the province of British Columbia, Canada, and the state of Utah. The company develops barium and iodine-based APIs. The company was formerly known as Voyageur Minerals Ltd.

Further Reading

Receive News & Ratings for Voyageur Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Voyageur Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.